| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Allen Monty K serves as a Director at IRMD. Across recent SEC filings that breaks down to 0 buys and 23 sells. Those positions are worth an estimated $1.7M at current prices.
Historically, Allen Monty K's trades have earned a below-average insider score of 47/100 across 7 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -13.3%.
The biggest single holding is IRMD (~$1.7M) as Director. The recent filings there lean toward selling, a net 67,792 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2019 | IRMD Iradimed Corp | - | Sell | 8,038 | $24.74 | $198,861.84 | -34.0% | |
| Mar 5, 2019 | IRMD Iradimed Corp | - | Sale+OE | 10,000 | $25.39 | $253,945.00 | -29.7% | |
| Aug 9, 2018 | IRMD Iradimed Corp | - | Sell | 4,347 | $27.04 | $117,526.36 | -21.8% | |
| May 2, 2018 | IRMD Iradimed Corp | - | Sell | 1,899 | $17.94 | $34,068.06 | -8.7% | |
| Dec 4, 2017 | IRMD Iradimed Corp | Director | Sell | 1,898 | $13.95 | $26,477.10 | -17.3% | |
| Jun 14, 2016 | IRMD Iradimed Corp | Director | Sell | 2,275 | $20.00 | $45,500.00 | -100% | |
| Jun 13, 2016 | IRMD Iradimed Corp | Director | Sale+OE | 2,100 | $20.44 | $42,930.72 | -48.0% | |
| Aug 25, 2015 | IRMD Iradimed Corp | Director | Sell | 6,250 | $24.85 | $155,303.70 | -100% |